Purpose: Prior studies have suggested associations with vitamin D concentrations, increased survival and prognosis in patients with lymphoma and multiple myeloma (MM); however little is known about patients undergoing autologous hematopoietic stem cell transplant (AHSCT). We, thus, investigated pre-AHSCT 25-hydroxyvitamin D [25(OH)D] concentrations and transplant related parameters to determine incidence of vitamin D insufficiency and overall survival in subjects diagnosed with MM and lymphoma. Methods: An IRB approved waiver of consent retrospective analysis was performed at Seattle Cancer Care Alliance (SCCA) Results: 83 patients in the control group received G-CSF beginning day +1, and 56 study group patients received G-CSF beginning day +7. There was a significant difference in ANC recovery both to >500 and >1500 between the groups. On average, patients who received G-CSF starting Day +7 required 1.53 more days for ANC recovery >500 and 1.89 more days for ANC recovery >1500. However, there was no statistical difference in platelet reconstitution or length of stay. Conclusion: Day +1 administration of G-CSF was associated with earlier neutrophil recovery but there was no improvement in incidence of infection or length of stay when compared to administration beginning day +7. 
